biomedicina slovenica

re="Clinical : 501-600

  1. Čater N; Pavlovič L
    Pharmaceutical care is an important project in the prevention of the diseases
    2002 ►
  2. Štotl J; Čufer T; Kozjek F; Sonc M
    Comparison of quality of lif of breast cancer patients, treated with two diferent chemotherapeutic schemes
    2002 ►
  3. Kobal Nataša; Kariž Stojan
    Use of antimicrobial drugs in General hospital Izola from 1996 to 2000
    2002 ►
  4. Mitrovič S; Miharija-Gala T; Tegelj I; Urh S; Baler M
    Preparation and testing of acetylcysteine solurion for individual treatment
    2002 ►
  5. Baler M; Tršan M; Miharija-Gala T
    Individualized therapy and potentiometric titration of active ingredients
    2002 ►
  6. Vodopivec V; Miharija-Gala T; Tršan M; Baler M
    Cardioplegia solution: preparation and stability
    2002 ►
  7. Šantel Z; Mušič E; Primožič S
    Pharmacokinetic interactions of theophylline with other drugs
    2002 ►
  8. Rupnik-Ravnihar I; Kozjek F; Antolič G
    Pharmacokinetic/pharmacodynamic modelling of tramadol
    2002 ►
  9. Schweiger E; Kozjek F; Antolič G
    Prediction of pharmacokinetic parameters of nitrendipine by artificial neural networks
    2002 ►
  10. Sikošek-škulj T; Stamos V; Bačar C; Kozjek F
    Kinetics of lithium carbonate and thyroid stimulating hormone interaction
    2002 ►
  11. Skerbinjak-Kavalar M; Brunčko A; Primožič S; Kos M; Lampe-Ivanovska D; Strbad E
    Follow-up of safety and effectiveness of fluticasone propionate in children and adolescents with asthma
    2002 ►
  12. Miharija-Gala T; Obersnel D; Lubej M
    Influence of the clinical pharmacist on rational preparation and consumption of drugs for pain management
    2002 ►
  13. Peklar J; Tratar F; Mrhar A
    Cost effectiveness analysis of implementation of drug formulary for antimicrobials in General hospital Celje
    2002 ►
  14. Silič A; Janež A; Kozjek F; Tomažič J
    Metabolic abnormalities associated with highly active antiretroviral therapy (HAART) in HIV infected patients in Slovenia
    2002 ►
  15. Borovničar A; Keber I
    Improvement of functional parameters of arterial wall and microcirculation in subjects with hypercholesterolemia after vitamin E supplementation
    2002 ►
  16. Košnik Mitja
    New drugs and delivery systems in the treatment of asthma
    2002 ►
  17. Eržen R; Mušič E; Tomič V; Remškar Z
    Analysis of hospital treated community-acquired pneumonia
    2002 ►
  18. Štabuc-Šilih M; Štabuc B
    Keratoconus and ehlers-danlos syndrome
    2002 ►
  19. Hawlina M; Hvala A; Perkovič T
    Ultrastructure of human anterior lens capsule in intumescent white cataracts
    2002 ►
  20. Trontelj Jože V; Sanders Donald B; Stalberg Erik V
    Electrophysiological methods for assessing neuromuscular transmission
    2002 ►
  21. Čokolič M; Hren R
    Alendronate treatment of male patients with idiopathic osteoporosis
    2002 ►
  22. Hren R; Breznik M; Čokolič M
    Quality of life issues in postmenopausal osteoporosis: the patient's perspective
    2002 ►
  23. Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J; Cimerman N
    Balance in asthma between serum cysteine proteinases and their inhibitors
    2002 ►
  24. Božič B; Čučnik S; Ambrožič A; Lestan B; Kos-Golja M; Rozman B; Kveder T
    Antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
    2002 ►
  25. Svetic B; Vrhovec I; Kramberger M; Borštnar S; Čufer T
    The influence of different buffers on tumor tissue preparation for biochemical determination of cathepsins D and L
    2002 ►
  26. Avberšek-Lužnik I; Benedik M; Malešič I; Marc J
    Serum osteoprotegerin level and bone turnover in dialysis patients
    2002 ►
  27. Prezelj M; Kersnik M; Schara M
    Effect of superoxide generated by xanthine oxidase/hypoxanthine system on red blood cell
    2002 ►
  28. Pajič T; Zagradišnik B; Urlep-Šalinovič V; Kokalj-Vokač N; Kralj J
    FV Leiden, Protrombin G20210A and methylenetetrahydrofolate reductase C677T mutation detection on the lightcycler
    2002 ►
  29. Meško-Brguljan Pika; Bratož Saša
    Quality and accreditation of clinical chemistry laboratories: state-of-the-art in Slovenia
    2002 ►
  30. Šeruga T
    Percutaneous vertebroplasty in patients with spine compression fractures due to osteoporosis
    2002 ►
  31. Pečovnik-Balon Breda; Hojs Radovan; Bren Andrej
    Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy
    2001 ►
  32. Sonc M; Beravs A; Kozjek F; Primožič S
    Pharmacoeconomic analysis of lung cancer treatment with gemcitabine
    2001 ►
  33. Perharič L; Maver S; Jamšek M
    Cerebral infarction due to phosphine gas poisoning
    2000 ►
  34. Šarc L; Jamšek M
    DMPS in the treatment of chronic lead poisoning
    2000 ►
  35. Grošelj C; Kukar M
    Improving the accuracy of myocardial perfusion scintigraphy results by machine learning method
    2002 ►
  36. Fidler Valentin; Prepadnik Milan
    Upgrading of analogue gamma cameras with PC based computer system
    2002 ►
  37. Pirnat E; Fidler V; Zaletel K; Gaberšček S; Hojker S
    The early changes of thyroid hormone concentrations after 131I therapy for graves' hyperthyroidism - the role of pretreatment with methimazole
    2002 ►
  38. Zaletel K; Gaberšček S; Pirnat E; Hojker S
    Incidence of hyperthyroidism in Slovenia since improved iodine supply
    2002 ►
  39. Koselj Miha; Koselj Mira; Kandus Aljoša; Bren Andrej
    Infectious complications of immunosuppressive treatment for Anca-related vasculitis
    2002 ►
  40. Bren Andrej; Kandus Aljoša; Kovač Damjan; Koselj Mira; Buturović Jadranka; Lindič Jelka; Vizjak Alenka; Ferluga Dušan
    Outcome and prognosis of cyclosporine (CS) related hemolytic-uremic syndrome (HUS) in kidney graft recipients - clinical and histopathologic study of 13 cases
    2002 ►
  41. Marc Janja
    Bone remodelling in diabetes mellitus
    2001 ►
  42. Bren Andrej; Koselj Mira; Kandus Aljoša; Kovač Damjan; Lindič Jelka; Črnej Alja; Grego Katarina
    Severe fungal infections in kidney graft recipients
    2002 ►
  43. Ponikvar Rafael R; Kandus Aljoša S; Bren Andrej F; Buturovič-Ponikvar Jadranka
    Side effects of protein a immunoadsorption and plasma exchange therapy in renal allograft recipients
    2002 ►
  44. Stegnar Mojca
    Disturbances of hemostasis in diabetes mellitus contributing to the development of atherosclerosis
    2001 ►
  45. Buturovič-Ponikvar Jadranka; Novljan Gregor; Ponikvar Rafael
    Cosmetic side effects of immunosuppressive therapy in children and adolescents with renal graft
    2002 ►
  46. Černe Darko
    Early detection of chronic complications: diabetic nephropathy
    2001 ►
  47. Koselj Mira; Kandus Aljoša; Bren Andrej
    Posttransplant diabetes mellitus - a serious complication of immunosuppression in renal allograft recipients
    2002 ►
  48. Božič Borut
    Diabetes and autoimmunity
    2001 ►
  49. Černelč Peter
    Maintenance treatment of primary plasma cell leukemia with interferon alpha
    2002 ►
  50. Preložnik-Zupan Irena; Zver Samo; Pretnar Jože
    Immunosuppresive treatment of severe acute graft versus host disease after allogeneic haematopoetic stem cell transplantation
    2002 ►
  51. Kandus Aljoša
    Prevention of acute rejection with basiliximab and triple immunosuppression after renal transplantation
    2002 ►
  52. Modic Mojca; Černelč Peter; Zver Samo
    Should be splenectomy really the last option of immunosupressive therapy in patients with chronic or relapsing idiopathic thrombotic thrombocytopenic purpura
    2002 ►
  53. Lokar L; Urlep-Šalinović V; Zagradišnik B; Kokalj-Vokač N
    Correlation beetwen ProC Global assay and coagulation inhibitor assays
    2001 ►
  54. Kastelic Andrej; Kostnapfel-Rihtar Tatja
    Integrating methadone treatment in the Slovenian public health system
    1999 ►
  55. Stalberg Erik; Falck Bjoern
    The role of electromyography in neurology
    2001 ►
  56. Samama Meyer Michel; Desnoyers Pierre; Gerotziafas Grigoris T
    Low molecular weight heparins: a comparative review of pharmacodynamic, clinical pharmacology
    2001 ►
  57. Samama MM; Kher A
    Anticoagulation: the old and new
    2001 ►
  58. Scholz T; Krause S; Finkelberg L; Loesche W
    Detection of small platelet aggregates and their inhibition by glycoprotein IIb/IIIa antagonists in a laser aggregometer
    2001 ►
  59. Niessner A; Kaun C; Christiansen G; Pedersen AS; Simon S; Zorn G; Georgopoulos A; Graninger W; Huber K; Wojta J
    Outer membrane protein 11 (OMP 11) and OMP 15 of Chlamydia pneumoniae induce the chemokine interleukin-8 (IL-8) and the pro-inflammatory cytokine IL-6 in human endothelial cells in vitro
    2001 ►
  60. Weiss T; Macfelda K; Kaun C; Zorn G; Kapeller B; Springer C; Bialy J; Losert UM; Breuss JM; Binder BR
    Inflammatory cytokines and growth factors regulate plasminogen activator inhibitor-1 (PAI-1) in human adult cardiac myocytes (HACM)
    2001 ►
  61. Miles LA; Green M; Gong A; Jardi M; Felez J
    Monoclonal antibodies detect receptor-induced binding sites (RIBS) in plasminogen induced by its interaction with cells
    2001 ►
  62. Barrowcliffe TW; Jardi M; Cancelas JA; Rabaneda M; Fabregas P; Felez J
    Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid
    2001 ►
  63. Barrowcliffe TW; Rabaneda M; Gray E; Felez J
    Procoagulant activity of activated endothelial cells - the importance of negatively charged phospholipids
    2001 ►
  64. Speidl WS; Graf S; Nikfardjam M; Niessner A; Zorn G; Wojta J; Huber K
    High sensitivity C-reactive protein predicts risk for further coronary events in stable patients with premature coronary artery disease
    2001 ►
  65. Hiltunen L; Paunio M; Kaaja R; Vahtera E; Krusius T; Rasi V
    A prospective nested case control study of thromboembolic complications of pregnancy
    2001 ►
  66. Kuismanen K; Salonvaara M; Mononen T; Riikonen P
    Treatment of a newborn with neonatal purpura fulminans in a family with hereditary type II protein C deficiency
    2001 ►
  67. Niessner A; Hornykewycz S; Joerg M; Zorn G; Graf S; Binder BR; Huber K
    Increased risk of restenosis after successful percutaneous transluminal coronary angioplasty in patients with permanently elevated anticardiolipin antibodies
    2001 ►
  68. Michiels JJ; Kasbergen HAA; Trienekens PH
    Evidence for safe exclusion of deep vein thrombosis (DVT- by a rapid ELISA D-dimer test in 434 consecutive outpatients with suspected DVT
    2001 ►
  69. Michiels JJ; Posthuma W; Ponjee GAE; Stef E; Quint WG; van Doorn LJ
    DNA typing for thrombophilia-related factor V leiden and prothrombing G20210A mutations by multiplex PCR and reverse hybridisation LiPA in 473 thrombosis patients
    2001 ►
  70. Furlan M
    New strategies in diagnosis and treatment of thrombocitic thrombocytopenic purpura
    2001 ►
  71. Vermylen J
    Heparin-induced thrombocytopenia
    2001 ►
  72. Prandoni P
    The optimal treatment of venous thrombosis
    2001 ►
  73. Vermylen J
    Platelet glycoprotein receptor antagonists
    2001 ►
  74. Felez J
    Cell surface associated fibrinolysis
    2001 ►
  75. Blinc A
    Transport of fibrinolytic agents as a rate-limiting step in fibrinolysis and thrombolysis
    2001 ►
  76. Palareti G
    Laboratory and therapeutic quality control of anticoagulant treatment: an update
    2001 ►
  77. Collen D; Lijnen HR
    Recent developments in thrombolytic therapy
    2001 ►
  78. Lijnen HR
    Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems
    2001 ►
  79. Lowe GDO
    Lipoprotein(a) and cardiovascaular disease
    2001 ►
  80. Lowe GDO
    Fibrinogen, fibrin D-dimer and cardiovascular disease
    2001 ►
  81. Juhan-Vague I; Alessi MC; Morange PE
    Hypofibrinolysis and increased PAI-I are linked to atherothrombosis via insulin resistance and obesity
    2001 ►
  82. Iacoviello L; Donati MB
    Gene-environment interactions: the example of coagulation factors
    2001 ►
  83. Castoldi E; Bernardi F
    Factor V markers for the detection of genetic components of APC resistance in venous thrombosis
    2001 ►
  84. de Gaetano G; Rotondo S
    Mediterranean diet and cardiovascular disease
    2001 ►
  85. Wiman B
    Fibrinolytic factors in connection with cardiovascular disease
    2001 ►
  86. Pabinger-Fascing I
    Thrombophilia - a multigene defect
    2001 ►
  87. Bertina R
    Identification of molecular risk markers for thrombosis
    2001 ►
  88. Schved JF; Giansily M
    Tissue factor and tissue factor pathway inhibitor: from fundamental to clinic
    2001 ►
  89. Binder BR
    Arterial thrombosis. Pathomechanism, prediction and therapy
    2001 ►
  90. Geiger M
    Protein C inhibitor
    2001 ►
  91. Perrier A
    D-dimer testing in suspected venous thromboembolism
    2001 ►
  92. Ten Cate H
    Markers of blood coagulation activation
    2001 ►
  93. Gaffney PJ
    Fibrin degradation products. A review of structures found in vitro and in vivo
    2001 ►
  94. Galli M
    Antiphospholipid antibodies: predictive value of laboratory tests
    2001 ►
  95. Kluft C
    Standardization of fibrinolysis methods
    2001 ►
  96. Bazzoni G; Martinez-Estrada OM; Dejana E
    Molecular architecture of interendothelial junctions
    2001 ►
  97. Levy-Toledano S
    Platelet signal transduction pathways: could we organize them into a "hierarchy"
    2001 ►
  98. Poredoš P
    Endothelial dysfunction in the pathogenesis of atherosclerosis
    2001 ►
  99. Vodušek DB; Bemelmans B; Chancellor M; Coates K; van Kerrebroeck P; Opsomer RJ; Schmidt R; Swash M
    Clinical neurophysiology
    2001 ►
  100. Trontelj JV
    Single fibre electromyography: guidelines for fibre density estimation and jitter measurement by axonal microstimulation
    2001 ►

   1 101 201 301 401 501 601 701 801 901  

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko